TUHURA BIOSCIENCES, INC./NV

Profile

Company Names

TUHURA BIOSCIENCES, INC./NV
KINTARA THERAPEUTICS, INC.
DELMAR PHARMACEUTICALS, INC.

Addresses

10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL 33612

10500 UNIVERSITY DR., SUITE 110, TAMPA, FL 33612

12707 HIGH BLUFF DR., SUITE 200, SAN DIEGO, CA 92130

SUITE 720-999 WEST BROADWAY, VANCOUVER, A1 V5Z 1K5

Phone Numbers

813-875-6600
(813) 875-6600
858-350-4364
(604) 629-5989

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

NEVADA

Total Amount Raised:

$41,600,043.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-10-27 
$1,500,000.00 
$3,000,000.00 
$1,500,000.00 
Equity 
4
2025-06-02 
$2,228,043.00 
$12,612,120.00 
$10,384,077.00 
Equity 
3
2020-08-19 
$21,772,000.00 
$30,000,000.00 
$8,228,000.00 
Equity 
2
2016-04-29 
$5,600,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2013-01-25 
$10,500,000.00 
$10,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BACHA 
EXECUTIVE OFFICER, DIRECTOR
SERNOVA CORP.   |  DELMAR PHARMACEUTICALS, INC.   |  EDISON ONCOLOGY HOLDING CORP
JOHN 
K 
BELL 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.
JOHN 
K. 
BELL 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.   |  CANOPY RIVERS CORP
JAMES 
 
BIANCO 
EXECUTIVE OFFICER, DIRECTOR
MORPHOGENESIS INC   |  TUHURA BIOSCIENCES, INC.   |  TDJC MEDIA PRODUCTIONS LLC   |  TUHURA BIOSCIENCES, INC./NV
DENNIS 
 
BROWN 
EXECUTIVE OFFICER, DIRECTOR
C3 JIAN INC   |  MERGE HEALTHCARE INC   |  DELMAR PHARMACEUTICALS, INC.   |  CELL SOURCE, INC.   |  KINTARA THERAPEUTICS, INC.   |  AZORA THERAPEUTICS, INC.
LYNDA 
 
CRANSTON 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.
DAN 
 
DEARBORN 
EXECUTIVE OFFICER
MORPHOGENESIS INC   |  TUHURA BIOSCIENCES, INC.   |  TUHURA BIOSCIENCES, INC./NV
WILLIAM 
 
GARNER 
DIRECTOR
LIVETIMENET INC   |  LTN GLOBAL COMMUNICATIONS, INC.   |  DELMAR PHARMACEUTICALS, INC.   |  UPDATE PHARMA, INC.
LISA 
 
GUISE 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.
ROBERT 
 
HOFFMAN 
DIRECTOR
PRINCETON OPPORTUNITY PARTNERS, LP   |  COMBIMATRIX CORP   |  SG HOLDINGS, LLC   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  SHENANDOAH GROWERS, INC.   |  ANAPTYSBIO INC   |  KINTARA THERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC./NV   |  FIBROBIOLOGICS, INC.
LAURA 
 
JOHNSON 
DIRECTOR
SYMETRA SEPARATE ACCOUNT VL   |  SALTY GIRL SEAFOOD, INC.   |  KINTARA THERAPEUTICS, INC.   |  SYPHER, INC.   |  FIRST CAPITAL BANCSHARES INC /SC/
JOHN 
 
LIATOS 
EXECUTIVE OFFICER, DIRECTOR
KINTARA THERAPEUTICS, INC.
ALAN 
 
LIST 
DIRECTOR
TUHURA BIOSCIENCES, INC.   |  TUHURA BIOSCIENCES, INC./NV
JAMES 
 
MANUSO 
DIRECTOR
OCUPHIRE PHARMA, INC.   |  TUHURA BIOSCIENCES, INC.   |  OPUS GENETICS, INC.   |  TUHURA BIOSCIENCES, INC./NV
ERICH 
 
MOHR 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.   |  NEURODYN COGNITION INC.   |  BROOKLYN IMMUNOTHERAPEUTICS, INC.
KEITH 
 
MURPHY 
DIRECTOR
ORGANOVO, INC.   |  ORGANOVO HOLDINGS, INC.   |  KINTARA THERAPEUTICS, INC.   |  VISCIENT BIO, INC.
GEORGE 
 
NG 
DIRECTOR
MORPHOGENESIS INC   |  GGWP, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC.   |  CALIDI BIOTHERAPEUTICS, INC.   |  TUHURA BIOSCIENCES, INC./NV
SCOTT 
 
PRAILL 
EXECUTIVE OFFICER
DELMAR PHARMACEUTICALS, INC.   |  KINTARA THERAPEUTICS, INC.
STEVEN 
 
RYCHNOVSKY 
EXECUTIVE OFFICER
KINTARA THERAPEUTICS, INC.
CRAIG 
 
TENDLER 
DIRECTOR
TUHURA BIOSCIENCES, INC./NV
ROBERT 
 
TOTH 
DIRECTOR
DELMAR PHARMACEUTICALS, INC.   |  ALPHAQUEST ORIGINAL LLC   |  KINTARA THERAPEUTICS, INC.   |  MATRIXONE PARTNERS LLC SERIES 1   |  QUEST PARTNERS LLC   |  QUEST INSTITUTIONAL LLC
SAIID 
 
ZARRABIAN 
EXECUTIVE OFFICER, DIRECTOR
AMBIT BIOSCIENCES CORP   |  CYNTELLECT, INC   |  INTREXON CORP   |  LA JOLLA PHARMACEUTICAL CO   |  KINTARA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-27 
2025-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-02 
2020-08-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
2020-08-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
2016-05-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2016-04-29 
2013-03-07
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-25 
2013-02-14
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-25 
2013-02-08
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-25 
2013-02-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2013-01-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
5670
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC
44656
NONE
NONE
AEGIS CAPITAL CORP.
15007
NONE
NONE
NEWPORT COAST SCURITIES INC
16944
NONE
NONE
AEGIS CAPITAL CORP
15007
NONE
NONE
CHARLES VISTA, LLC
132650